SEC Filing Update: #INBX Inhibrx Biosciences, Inc. : $79.56

Sector: Healthcare | YTD: 🔼+ 6.28% The SEC disclosed Today (13-NOV-2026) that SCHONFELD STRATEGIC ADVISORS LL has INCREASED #INBX Shares by 21.91% 🟢 * Previous Holdings: 781.68K Shares * Current Holdings: 952.96K Shares * Increase+171.28K * Increased(%)+21.91% * Ownership: 6.47% * Estimated Investment Value: $14.48M https://www.thinksabio.com/reports/isr/INBX Institutional ownership in #INBX has been steadily rising over the past 2 quarters in Shares: Q1 2026: 12.71M Q2 2026: 13.44M 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free →